MITOCHONDRIAL PEPTIDE
16 AMINO ACIDS
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
PEPTIDE PERFORMANCE RESEARCH LIBRARY
An educational overview of a mitochondrial-derived peptide being studied for its relationship to metabolic signaling, cellular stress responses, skeletal muscle biology, and mitochondrial function.
RESEARCH OVERVIEW
MITOCHONDRIAL PEPTIDE
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
CELL SIGNALING
During metabolic stress, research suggests MOTS-C can participate in signaling between mitochondria and the nucleus and influence expression of stress-responsive genes.
RESEARCH STATUS
MOTS-C has generated significant research interest, but experimental administration remains primarily a preclinical area of investigation.
MECHANISMS UNDER INVESTIGATION
Research is examining how mitochondrial-derived signaling may influence cellular adaptation to metabolic stress.
MOTS-C research has implicated AMPK-associated pathways, which play important roles in cellular energy sensing and metabolic adaptation.
Animal and cellular studies have examined effects on glucose utilization, insulin sensitivity, substrate metabolism, and metabolic homeostasis.
Current work includes investigation of mitochondrial efficiency, cellular stress resistance, and skeletal muscle bioenergetics.
CURRENT EVIDENCE
PRECLINICAL RESEARCH
Experimental studies have investigated MOTS-C in models involving obesity, insulin resistance, skeletal muscle metabolism, aging, inflammation, and cellular stress.
HUMAN RESEARCH
Human studies have measured naturally occurring MOTS-C in relation to exercise, metabolic states, aging, and disease-associated biomarkers.
IMPORTANT CONTEXT
Observing naturally occurring MOTS-C in humans is not equivalent to demonstrating that externally administered MOTS-C is safe or clinically effective.
EXERCISE BIOLOGY
Exercise-related research has reported changes in circulating or tissue-associated MOTS-C and has contributed to interest in its possible role in metabolic adaptation.
These findings primarily describe biological associations and should not be interpreted as evidence that MOTS-C administration reproduces the established benefits of exercise.
RESEARCH LIMITATIONS
Much of the experimental evidence involving administered MOTS-C comes from cellular and animal research.
Human studies are useful for understanding endogenous mitochondrial signaling, but they do not yet establish a standardized therapeutic indication, long-term safety profile, clinical dosing framework, or proven clinical benefit from experimental MOTS-C administration.
RESEARCH SOURCES
Discovery & Metabolic Research
Lee C, Zeng J, Drew BG, et al.
The mitochondrial-derived peptide MOTS-c promotes
metabolic homeostasis and reduces obesity and insulin
resistance. Cell Metabolism. 2015.
Metabolism & Aging Review
Research reviews have examined MOTS-C in metabolic
regulation, cellular stress responses, aging,
cardiovascular biology, and mitochondrial signaling.
Human Exercise Research
Human studies have evaluated circulating MOTS-C responses
and associations with exercise and metabolic conditions.
Current Mitochondrial Research
Ongoing experimental work continues to investigate
mitochondrial bioenergetics, AMPK-related signaling,
muscle biology, and cellular stress responses.
EDUCATIONAL RESEARCH NOTICE
Information presented in the Peptide Performance Research Library is provided for general educational and scientific reference purposes only.
This content is not medical advice, diagnosis, treatment guidance, dosing information, or personal-use instruction. Research findings may change as additional evidence becomes available.